Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01IRX
|
|||
| Former ID |
DNC002175
|
|||
| Drug Name |
ISIS 19657
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HER4 messenger RNA (ERBB4 mRNA) | Target Info | . | [1] |
| KEGG Pathway | ErbB signaling pathway | |||
| Calcium signaling pathway | ||||
| Endocytosis | ||||
| Proteoglycans in cancer | ||||
| Panther Pathway | Alzheimer disease-presenilin pathway | |||
| Cadherin signaling pathway | ||||
| EGF receptor signaling pathway | ||||
| WikiPathways | ErbB Signaling Pathway | |||
| EV release from cardiac cells and their functional effects | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,255,111, Antisense modulation of Her-4 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.